Digital Health Global

JANUARY 10, 2024

As we look forward to an exhilarating 2024, we believe this partnership will pave the way for significant advancements in the field of drug R&D for the benefit of the patients,” explained Khai Pham, CEO of ThinkingNodeLife.ai Debiopharm’s main activities include drug development, drug manufacturing and digital health investment.

Drug Development 88

Drug Development Pharmaceuticals Digital Health 88

FierceHealthIT

DECEMBER 11, 2020

Optum: Why COVID-19 could significantly change the drug development pipeline. Fri, 12/11/2020 - 12:12.

Drug Development 135

Drug Development 135

Mobi Health News

OCTOBER 1, 2020

Valo Health’s Opal Computational Platform uses machine learning, cloud computing and real-world data to assist in the drug discovery and development process.

Drug Development 213

Drug Development 213

Digital Health Global

JANUARY 26, 2024

Under the program, Deliberate AI’s assessment tool for anxiety and depression, the AI-generated Clinical Outcome Assessment or AI-COA , will receive support to become a qualified drug development tool (DDT). Global experts have also expressed support for Deliberate AI’s innovative approach.

Drug Development 88

Drug Development Mental health Psychiatry Digital Health 88

FierceHealthIT

MAY 3, 2021

Optum: Why payers should be watching flurry of drug development activity around eczema. Mon, 05/03/2021 - 15:53.

Drug Development 106

Drug Development 106

FierceHealthIT

JANUARY 20, 2022

Fierce JPM Week: How 23andMe plans to harness its massive database to further its ambitions in drug development. Thu, 01/20/2022 - 17:06.

Drug Development 106

Drug Development 106

FierceHealthIT

JULY 11, 2019

Startup Medicare Advantage insurer Clover Health has launched a new drug development subsidiary called Clover Therapeutics.

Drug Development 92

Drug Development Medicare 92

ActiGraph

SEPTEMBER 23, 2021

Oncology is one of the most active and fastest growing areas of drug development research, outpacing other therapeutic areas in terms of study volume, complexity, cost, and duration.

Drug Development 52

Drug Development 52

ActiGraph

SEPTEMBER 23, 2021

Oncology is one of the most active and fastest growing areas of drug development research, outpacing other therapeutic areas in terms of study volume, complexity, cost, and duration.

Drug Development 52

Drug Development 52

Mobi Health News

DECEMBER 28, 2022

Drug development platform Quris raised another $9 million, and PharmStars is accepting applications for its accelerator cohort focused on women's health and health equity.

Drug Development 293

Drug Development Digital Health 293

ActiGraph

JUNE 21, 2024

The need to transform the clinical trial process to deliver more effective treatments to patients faster is greater than ever, and a key part of this transformation is a focus on putting the patient first.

Drug Development 52

Drug Development Digital Health Health Technology 52

Mobi Health News

JULY 9, 2019

From streamlining operations to fine-tuning optimal treatments, the technology makes a business case for pharma.

Drug Development 205

Drug Development 205

Mobi Health News

JULY 10, 2019

Dubbed Clover Therapeutics, the unit's first project will be a partnership with Genentech targeting ocular diseases among senior populations.

Drug Development 199

Drug Development 199

Mobi Health News

APRIL 5, 2022

The multiyear agreement will focus on speeding clinical trials and drug development in oncology and nonalcoholic steatohepatitis.

Drug Development 287

Drug Development 287

Mobi Health News

MAY 19, 2022

They aim to bring down the period and costs for new drug development.

Drug Development 309

Drug Development 309

Mobi Health News

JULY 15, 2021

Also: Entos works to improve drug development after closing its Series A round and Castor plans to build out its decentralized clinical trial platform with a $45 million investment.

Drug Development 237

Drug Development Digital Health 237

KevinMD

MARCH 14, 2019

An important part of advancing medical research and drug development is making participation in clinical trials easier and more inclusive. To develop treatments that work on men, women, and children of all ages and different ethnicities we need to have clinical trial data that represents our diverse population.

Telemedicine 406

Telemedicine Drug Development Mobile Health 406

Digital Health Global

SEPTEMBER 19, 2023

Among these transformative innovations, artificial intelligence (AI ) stands out as a major force, reshaping the fields of drug discovery , drug development, clinical trials and patient care. The clinical trials phase represents a crucial turning point in drug development, but is often characterised by inefficiencies and delays.

Pharmaceuticals 167

Pharmaceuticals Drug Development Digital Health 167

ActiGraph

DECEMBER 27, 2021

During the recent Annual ASCO Meeting , thousands of cancer researchers and clinicians from across the globe joined together virtually to present and discuss the latest findings and breakthroughs in cancer research and care.

Drug Development 52

Drug Development 52

Healthcare IT Today

MAY 25, 2021

Curebase today announced $15M in Series A funding to continue developing its decentralized clinical trial software platform and virtual research site capabilities, powering research where any patient, anywhere, can be part of clinical trials at home and with their own doctor.

Drug Development 67

Drug Development Healthcare IT Health IT 67

ActiGraph

APRIL 17, 2024

The Digital Endpoint Collaboration to accelerate Outcome DEvelopment (DECODE) Nocturnal Scratch working group was launched in November 2023, with the goal of bringing to the market a fit-for-purpose digital measure of nocturnal scratch.

Patient Experience 94

Patient Experience Drug Development 94

Digital Health Global

FEBRUARY 19, 2024

This expansion mirrors a trend identified in an industry report jointly published by Biofourmis and HealthXL last year, predicting widespread adoption of digital endpoints by pharmaceutical companies in drug development programs by 2030.

Pharmaceuticals 166

Pharmaceuticals Drug Development Leadership Digital Health 166

Mobi Health News

FEBRUARY 19, 2019

BGN Technologies, the technology transfer company of Ben-Gurion University (BGU), today unveiled an artificial intelligence (AI) platform for monitoring and predicting the progression of neurodegenerative diseases for the purpose of identifying markers for personalised patient care and improved drug development.

Drug Development 206

Drug Development 206

Electronic Health Reporter

APRIL 8, 2022

Most people don’t realize that it can take up to 15 years and an average of $1 billion to $2 billion dollars just to get one drug developed, pass clinical trials and ultimately approved by […]. The article How Technology Is Improving Success Rates In Drug Clinical Trials appeared first on electronichealthreporter.com.

Drug Development 127

Drug Development 127

Healthcare IT Today

APRIL 14, 2022

Artificial intelligence (AI) holds great promise to dramatically improve clinical outcomes for patients, but in a perverse twist, AI algorithms that are used to improve drug development and support healthcare don’t just highlight social inequities — they may ultimately exacerbate them. A lingering […].

Drug Development 136

Drug Development Healthcare IT Health IT 136

Digital Health Global

MARCH 30, 2023

The FDA has announced several guidelines and plans to hold at least one public meeting on digital health technologies (DHTs) to be used in drug clinical trials by the end of the year. Drug development process questions the reliability and accuracy of DHT products.

Digital Health 167

Digital Health Health Technology Drug Development 167

Healthcare IT Today

NOVEMBER 24, 2021

The companies are evolving in many ways, including stepping outside drug development to tryout digital treatments and using lessons from the COVID-19 pandemic to rethink production and clinical trials. Where are pharma companies investing their windfall profits?

Drug Development 124

Drug Development Pharmaceuticals Healthcare IT Health IT 124

Digital Health Global

JANUARY 25, 2024

Biomarkers will help select patients whose cancer biologies are best suited to treatment with the right drug targeting the active disease mechanism. Debiopharm’s main activities include drug development, drug manufacturing and digital health investment.

Drug Development 88

Drug Development Digital Health 88

Digital Health Global

APRIL 5, 2024

Furthermore, the industry witnessed a decline in the average return on investment (ROI) for R&D to as low as 1.2%, and the peak sales per asset valued just above $350 million, indicating a need to build more efficient drug development processes with the implementation of newer technologies.

Drug Development 88

Drug Development Pharmaceuticals Digital Health Health Technology 88

hea!thcare innovation - Clinical IT

MAY 16, 2019

Real-world evidence has the potential to be especially valuable in a number of healthcare use cases

Drug Development 60

Drug Development 60

Digital Health Global

MARCH 2, 2023

As part of the partnership, SSI will expand Koneksa’s medical strategy division, especially in translational and clinical drug development. Koneksa clients gain access to a team of PhDs and MDs at SSI with expertise in drug development.

Life Science 88

Life Science Drug Development BioTech Leadership 88

Aging in Place Technology Watch

OCTOBER 16, 2024

Ask Google if AI is being used in health care – perhaps the Cleveland Clinic article will appear, talking for example, about scanning and finding information in health records, processing referral authorization claims, drug development, and chatbots for use at a patient’s bedside.

Drug Development 75

Drug Development Digital Health Health Information 75

Mobi Health News

APRIL 20, 2018

BenevolentAI, a UK company using artificial intelligence for drug development, has raised $115 million in new funding, mostly from undisclosed investors in the United States. Existing backer Woodford Investment Management also participated in the round, which brings the company’s total funds raised to over $200 million.

Drug Development 146

Drug Development 146

Digital Health Global

JUNE 13, 2023

We’re on a mission to revolutionize drug development in clinical trials by harnessing the power of our digital solutions with real-time, data-driven insights. “The utilization of evidence-based digital biomarkers is the key to transforming healthcare,” said Chris Benko, CEO, Koneksa. “We’re

Drug Development 88

Drug Development eMed BioTech Digital Health 88

Healthcare IT Today

MARCH 1, 2024

In this video, he describes other ways that AI can make drug development more efficient. At the design stage, a drug company can run millions of simulations to determine where risks lie and what parameters are most promising.

Drug Development 116

Drug Development Healthcare IT Health IT 116

Digital Health Global

JANUARY 9, 2024

The funding speaks to the global nature of pre-approval access and its increasing importance in the drug development process. “ Our mutual dedication to building new approaches to pharmaceutical drug development and patient care will help bring promising pre-approval medicine to patients around the world, faster and more equitably.

Pharmaceuticals 88

Pharmaceuticals Drug Development Digital Health Health Technology 88

Society for Participatory Medicine

FEBRUARY 1, 2023

The FDA issued a series of four patient-focused drug development (PFDD) guidance documents which outline how patient co-design needs to successfully happen. By the power vested in clinical research, the FDA now pronounces us patient and industry. You may now kiss the cancer survivor.

BioTech 145

BioTech Drug Development Meaningful Use Pharmaceuticals 145